Pacira Pharmaceuticals Inc (PCRX)

Gross profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Gross profit	US$ in thousands	451,597	427,612	401,278	312,319	314,314
Revenue	US$ in thousands	636,266	626,907	541,533	429,647	421,026
Gross profit margin		70.98%	68.21%	74.10%	72.69%	74.65%

December 31, 2023 calculation

Gross profit margin = Gross profit ÷ Revenue
= $451,597K ÷ $636,266K
= 70.98%

The gross profit margin of Pacira BioSciences Inc has exhibited some fluctuations over the past five years. In 2023, the gross profit margin increased to 72.64% from 70.11% in 2022. This suggests that the company was able to generate more gross profit relative to its revenue in 2023 compared to the previous year. However, the margin in 2023 was slightly lower than the margin in 2021, which stood at 74.10%.

Overall, the trend in gross profit margin indicates some variability but generally reflects a strong ability to manage production costs and pricing strategies to generate profits from its core operations. The company may benefit from further scrutiny of cost efficiencies and pricing strategies to maintain or improve its gross profit margin in the future.